June 1, 2012
/PRNewswire/ -- Allscripts Healthcare Solutions, Inc. (Allscripts – NASDAQ: MDRX) and HealthCor Management, L.P. ("HealthCor") today announced that Allscripts will nominate
Stuart L. Bascomb
David D. Stevens
as new independent directors for election to the Allscripts Board of Directors at the Company's 2012 Annual Meeting of Stockholders scheduled for
, 2012. All three are highly-qualified professionals with significant expertise in the healthcare industry, each having previously served on the boards of directors of public companies and private organizations.
Allscripts and HealthCor also announced that, pursuant to their agreement, HealthCor will withdraw its claims against the Company currently pending in the Court of Chancery for the
State of Delaware
and will vote for all of the Company's nominees at the 2012 annual meeting. HealthCor currently owns approximately 6.1% of the outstanding shares of Allscripts' common stock.
, Chief Executive Officer of Allscripts, said, "We welcome the addition of Stuart, David and Randy and believe they will bring new perspectives and additional industry experience to our board. Taken together with the recent additions of
, the Company will have added five, high-quality, independent directors in just the past few weeks. We believe this is a positive outcome for Allscripts and its stockholders and we look forward to working collaboratively as we continue to implement our strategic initiatives and make the important and necessary investments to deliver a connected community of health for our clients and build value for all of our stockholders."
Arthur B. Cohen
, co-founder and Portfolio Manager of HealthCor, said, "We are pleased to have reached this amicable resolution with Allscripts, which we believe will serve the best interests of all stockholders. We continue to believe that Allscripts has great products, strong capabilities and a unique installed base of customers. Furthermore, we are confident that Stuart, David and Randy will make strong additions to the Board, and will work hard to represent all stockholders and assist the Company in seizing the tremendous market opportunity before it."
In addition to the three new independent nominees, the Company's nine-member slate for election at the 2012 annual meeting will consist of:
. Of the nine board members, eight are independent.
Stockholders of record as of
April 24, 2012
are entitled to vote at the Annual Meeting.
Stuart L. Bascomb
currently serves as the Chairman and Chief Executive Officer of QualSight, Inc., start-up company in
to create a nationwide network of ophthalmologists to market a managed care refractive surgery program to plan sponsors. Mr. Bascomb has a broad range of experience in the healthcare industry. He was a founder of Express Scripts in 1986 and helped lead its IPO in 1992 as the company's CFO. In addition, he served as Executive Vice President and Director at Express Scripts, Executive Vice President and Treasurer at Medicare-Glaser Corp. and Group Controller at Pet Incorporated.
Mr. Bascomb is a current member of the American Institute of CPA's. He served on the Board of Directors at St. Luke's Hospital and currently serves on its Strategic Planning Committee. He also served on the Boards of a number of pharmaceutical industry and charitable organizations, including, the Strategic Development Board of the
University of Missouri (Columbia)
School of Business, the American Institute of CPA's, the Financial Executive Institute, where he served as Director of the St. Louis Chapter,
March of Dimes, the Episcopal-Presbyterian Charitable Medical Trust, the Pharmaceutical Care Management Association and Past Chairman, the Chain Drug Industry's Accounting Principles Committee, the Chain Drug Industry's Administration and Operation.
Mr. Bascomb received his M.A. in Accounting from the
University of Missouri
and his A.B. in Business Administration from
William Jewell College
David D. Stevens
is actively involved as an investor/advisor in private equity, focusing on providing capital to lower-middle market growth companies in the healthcare services industry. Previously, Mr. Stevens served as Chief Executive Officer – AHG Division of Medco Health Solutions, Inc., where he was responsible, as the previous Chairman and Chief Executive Officer of Accredo Health Group, which was acquired by Medco, for the strategic direction and operation of the consolidated specialty pharmacy division of Medco (a reporting division of the parent), the largest specialty pharmacy provider in the market. From Accredo Health's IPO in 1999 to 2005, Mr. Stevens grew the company's revenue from approximately
. Medco Health acquired Accredo in
. Prior to working at Accredo, he served as Chief Operating Officer at Southern Health Systems, Inc. and Vice-President and Chief Operating Officer at Le Bonheur Children's Medical Center. Stevens currently serves on the Board of Directors of Wright Medical Group, Inc., where he is the Chairman of the Board and member of the Governance, Compliance & Nominating Committee. Previously, he served on the Boards of Medco Health Solutions, Inc. and Thomas & Betts Corporation, both public companies.
In addition, Mr. Stevens serves on the Board of Directors for three not-for-profit entities including Le Bonheur Children's Medical Center Foundation, Inc., Methodist Le Bonheur Health Systems, Inc., and The
University of Tennessee
Research Foundation. Mr. Stevens also actively serves on an advisory committee of the University Of Tennessee School Of Pharmacy.
Mr. Stevens received his MBA from Memphis State University and his B.S. in accounting from the
University of Tennessee
currently serves as the Senior Advisor and Operating Partner at New Mountain Capital LLC, a leading private and public equity firm with assets in excess of
. He has led or co-led transactions representing over
in enterprise value, and advised on private equity, public equity and debt transactions. Mr. Thurman has held a number of executive positions throughout his career, including Founder, Chairman and Chief Executive Officer of Viasys Healthcare Inc., where from the company's IPO in 2001 to 2007, Mr. Thurman grew the company's revenues from approximately
. Cardinal Health acquired Viasys in
. In addition, Mr. Thurman served as Chairman and Chief Executive Officer of Strategic Reserves International, Chairman and Chief Executive Officer of Coming Life Sciences Inc., President, Chief Executive Officer and Board Director of Rhone-Poulenc Rorer Pharmaceuticals and various positions with Exxon Enterprises and Pepsico International. Mr. Thurman also served as a fighter pilot for the United States Air Force.
Mr. Thurman has significant experience serving on the Boards of public companies and private organizations. Most recently he served as the Chairman of the Board of Directors for public company, CardioNet. Previously, he served on the Boards of Closure Medical Corporation, Curagen Inc. Rhone Poulenc Inc., Cooper Companies, Nichols Institute, Ikaria Inc., Hahneman University, High Flight of America, Corning Pharmaceutical Services, Metpath, Inc., Corning Life Sciences, Inc., Avantor, Performance Materials, and Rosenbluth International.